All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF IssuersInvescoRSPH
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

Passive ETFEquity

The RSPH Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: S&P 500 Equal Weight Health Care Index. The RSPH ETF provides physical exposure, so by buying it you actually own parts of all the 59 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$37.45
-$0.16 (-0.43%) yesterday
1:30 PM 08/28/26 Closed
1D price range
$37.33$37.58
52W price range
$28.42$38.05
YTD Perf.
+18.02%
YTD Flows
Annualized volatility
Fund AuM
€715M
Share class AuM
€715M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US46137V3327
TER
0.4%
Inception date
11/1/2006
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 28, 2026
-5%0%5%10%15%20%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
98.34%
Consumer Non-Cyclicals
1.66%
Latest RSPH news

No content available for this fund

FAQ about RSPH

RSPH is a Passive ETF. This ETF provides exposure to Equally Weighted Large Cap US Health Care Equities.
RSPH tracks the S&P 500 Equal Weight Health Care Total Return Index - USD, through a full replication replication method.
RSPH carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
RSPH was introduced to the market on November 1, 2006. It trades on United States
Invesco S&P 500® Equal Weight Health Care ETF, RSPH, is provided by Invesco. Learn more about Invesco here.
RSPH oversees €715M in assets as of August 28, 2026.
RSPH follows a distributing dividend policy, meaning it pays out income to investors. As of August 28, 2026, its 12-month trailing yield was 0.62%.
As of July 31, 2026, RSPH has significant geographic allocations in USA and Ireland.
As of July 31, 2026, RSPH focuses largely on Healthcare and Consumer Non-Cyclicals.
As of July 31, 2026, RSPH holds 59 positions in its portfolio, with 28.14% of assets concentrated in its top 15 holdings.
As of July 31, 2026, RSPH top three holdings include Bio-Techne Corp., IQVIA Holdings, Inc. and Veeva Systems, Inc..
The base currency of RSPH is USD.
Data as of 07/31/26
Bio-Techne Corp.
2.10%
IQVIA Holdings, Inc.
2.08%
Veeva Systems, Inc.
1.95%
Charles River Laboratories International, Inc.
1.93%
Mettler-Toledo International, Inc.
1.89%
Baxter International, Inc.
1.87%
DaVita, Inc.
1.86%
Abbott Laboratories
1.86%
Incyte Corp.
1.85%
Thermo Fisher Scientific, Inc.
1.83%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight